| 1 2 3 4 5 6 7 8 9 10 ... |
| |
|
| Japanese Researchers Will Use Stem Cells to Treat Spinal Cord Injuries in Groundbreaking Clinical Trial |
posted Wednesday, 20 February 2019 |
|
There could a new form of treatment in Japan for spinal cord injuries if a newly-approved clinical trial hits the mark. On Monday, a special committee of the Ministry of Health, Labor and Welfare in Japan approved a clinical research program at Tokyo’s Keio University to use induced pluripotent stem (iPS) cells to treat spinal cord injuries. According to the Nikkei Asian Review, this is a groundbreaking first-of-its-kind study. The clinical trial is expected to begin this summer...
|
|
Category:
Clinical Trials
|
|
|
| Spinal cord stimulator device shows promise in Minneapolis study |
posted Saturday, 16 February 2019 |
|
Learning to walk again would be great, but for many people with paralysis, shorter bathroom sessions would be a banner achievement.
An ongoing clinical study at Minneapolis hospitals called E-Stand is reporting early success using an implantable medical device designed in Minnesota called a spinal cord stimulator to restore volitional movement and autonomic functions in patients paralyzed from the...
|
|
Category:
Clinical Trials
|
|
|
| Spinal cord stimulator device shows promise in Minneapolis study |
posted Saturday, 16 February 2019 |
|
Learning to walk again would be great, but for many people with paralysis, shorter bathroom sessions would be a banner achievement.
An ongoing clinical study at Minneapolis hospitals called E-Stand is reporting early success using an implantable medical device designed in Minnesota called a spinal cord stimulator to restore volitional movement and autonomic functions in patients paralyzed from the...
|
|
Category:
Clinical Trials
|
|
|
| BioArctic's Product Candidate SC0806 for Treatment of Patients With Complete Spinal Cord Injury is now in Phase 2 |
posted Thursday, 14 February 2019 |
|
STOCKHOLM, Feb. 13, 2019 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the first patient in the second panel of the Phase 1/2 study now has been treated with SC0806. This means that the study with the product candidate SC0806 for complete spinal cord injury has progressed into Phase 2.
BioArctic develops a new innovative treatment for patients with complete spinal cord injury. The product candidate SC0806 is a combination of a biodegradable medical device and a drug substance (FGF1). SC0806 is designed to support nerve regeneration across the injured area in the spinal cord. Due to the novelty of the treatment, patients have been included sequentially, in order to monitor the effect and safety...
|
|
Category:
Clinical Trials
|
|
|
| Medical experts restore movement and autonomic function in patients with complete paralysis |
posted Sunday, 03 February 2019 |
|
MINNEAPOLIS, MN- January 31, 2019 - There are more than 290,000 people estimated to be living in the United States with a spinal cord injury. Previously, it has been shown that it is possible to restore some function to young and healthy patients within a few years of injury. Now, researchers show spinal cord stimulation can immediately restore some voluntary movement and autonomic functions such as cardiovascular, bowel, and bladder years after a paralyzing injury without any significant rehabilitation...
|
|
Category:
Clinical Trials
|
|
|
| Time to invest in spinal cord injury research |
posted Tuesday, 22 January 2019 |
|
Spinal cord injuries (SCI) are more likely in summer when increased numbers partake in more recreational outdoor pursuits. Such was the case of Ash Treseder who suffered a broken neck and severe spinal cord damage after diving from a pier in Shoal Bay, as the Herald reported on Saturday. A week in a spinal ward with other newly and not-so-newly injured patients (before the luckier ones walk out) is, for many, a life-changing experience...
|
|
Category:
Clinical Trials
|
|
|
|
| Helping paralyzed patients walk again |
posted Thursday, 10 January 2019 |
|
Jeff Marquis, a professional chef, loved nothing better than snowboarding, hiking, and mountain biking on the trails near his Montana home. Then, in 2011, catastrophe struck. Marquis, 29 at the time, was thrown from his bike. “I remember lying on the ground, realizing my hands weren’t working right and I couldn’t get up,” he says...
|
|
Category:
Clinical Trials
|
|
|
| For Mayo scientist, spinal-injury research is personal |
posted Monday, 03 December 2018 |
|
In September, Peter Grahn and his Mayo colleagues published a globally recognized breakthrough: using electrical stimulation and therapy exercises to help a paralyzed man walk the approximate length of a football field. Peter Grahn has faced the same question for a dozen years since he dived as a reckless teen into a southwest Minnesota lake, slammed headfirst into the shallow bottom, and floated — face down and motionless — on the surface...
|
|
Category:
Clinical Trials
|
|
|
| Immune cells could hold key to therapies for spinal cord injuries |
posted Thursday, 08 November 2018 |
|
Fresh insights into how zebrafish repair their damaged nerve connections could aid the development of therapies for people with spinal cord injuries. Scientists have found the immune system plays a key role in helping zebrafish nerve cells to regenerate after injury. The findings offer clues for developing treatments that could one day help people to regain movement after spinal cord injury. Large immune cells called macrophages are vital for the fish to repair damaged connections, the study found. These cells usually help the body to fight off infections but they also play a key role in wound healing.
|
|
Category:
Clinical Trials
|
|
| 1 2 3 4 5 6 7 8 9 10 ... |